Efficacy and tolerability of vemurafenib in patients with BRAF(V600E) -positive papillary thyroid cancer: M.D. Anderson Cancer Center off-label experience - Dadu, R; Shah, K; Busaidy, N L (J Clin Endocrinol Metab, 2015)
et al.